What medicine to take for breast hyperplasia

The disease of breast hyperplasia is too common, but there is no clear diagnosis and treatment method in life. Therefore, it is not possible to simply treat it with a few drugs after suffering from breast hyperplasia. The first step after breast hyperplasia occurs is to find the cause, and then determine what symptoms the patient has, judge the current stage of the disease based on the symptoms, and then give regular examinations and treatments before choosing whether to use medication for treatment.

1. What is the cause of breast hyperplasia?

Hyperplastic disease of breast is the most common breast disease, and its incidence ranks first among breast diseases. Fibrocystic breast disease is neither a tumor nor an inflammation, but rather an excessive proliferation or incomplete involution of the glands. Regarding the naming of breast hyperplasia, since many scholars at home and abroad have adopted different names according to the pathological characteristics and pathological changes of the disease, its naming is quite confusing, such as chronic fibrocystic breast disease, benign epithelial hyperplasia of the breast, lobular hyperplasia of the breast, mastalgia, breast disease, breast dysplasia, etc.

The cause of fibrocystic fibrosis has not yet been determined. It is generally believed that the relevant factors include: (1) endocrine factors. Most scholars believe that it is related to ovarian endocrine imbalance. Due to the increase in estrogen levels, decrease in progesterone levels or imbalance in the estrogen-progesterone ratio, excessive glandular proliferation or incomplete involution occurs, leading to fibrosis, breast pain, tissue structure disorder, varying degrees of proliferation of the mammary duct epithelium and fibrous tissue, and formation of cysts in the terminal glandular ducts or alveoli.

Clinical observations that anti-estrogen treatment of breast hyperplasia is effective support this view. However, no abnormalities were found in the plasma hormone levels of patients with fibrocystic breast disease. Therefore, some people have suggested that fibrocystic breast disease is related to the increased sensitivity of breast tissue to sex hormones.

(2) Decrease in essential fatty acids. Low plasma essential fatty acid levels and an increased ratio of saturated to unsaturated fatty acids may cause abnormal sensitivity of estrogen and progesterone receptors.

Breast pain is effectively treated with evening primrose oil rich in essential fatty acids, indicating that essential fatty acids have a certain effect on relieving breast pain.

(3) Social and psychological factors. In modern society, life and work are stressful, and the mind is often in a state of high tension, which is also one of the causes of breast pain.

(4) Lifestyle habits, such as a high-fat diet, may also play a role.

2. What are the symptoms of breast hyperplasia? How is it diagnosed?

Fibrocystic breast disease can occur in women of any age after puberty, but is most common in young and middle-aged women between the ages of 30 and 50. Its main clinical features are breast lumps and breast pain, which are generally cyclical, often aggravated before menstruation and relieved after menstruation. Sometimes they can radiate to the armpits or upper arms. They are more common in younger patients and may disappear on their own after menopause. Breast pain can also manifest as non-cyclical pain that is not related to the menstrual cycle. The pain is asymmetric, often unilateral and mostly localized, sharp or burning pain, and is more common in older patients.

The clinical diagnosis of fibrocystic breast disease includes complete medical history collection, physical examination, imaging examination and pathological examination when necessary. The history collected mainly includes the type of pain, relationship to menstruation, duration, location, and related problems. A comprehensive breast examination is very important. Any masses or nodules should be carefully examined, and any painful areas should also be examined in depth. By placing the patient in the side-lying position with the breast tissue hanging down from the chest wall, it is often possible to distinguish whether the pain is coming from the breast or from the deep ribs.

Color ultrasound examination is recommended as the preferred imaging examination for patients with breast hyperplasia, because the disease is gland-rich and most patients are under 40 years old. Ultrasound examination has much better resolution for nodules, cysts and solid tumors in dense glands than mammography. For older people with less glandular tissue, molybdenum target X-ray examination is the first choice, and a combined examination of the two can be performed if necessary. Of course, in some cases, it is difficult to differentiate them from fibroadenoma and breast cancer due to the formation of lumps or nodules, so necessary pathological histological examinations (core needle biopsy, fine needle aspiration cytology or surgical biopsy) are needed for diagnosis.

The diagnosis of breast hyperplasia is not difficult to make, but it should never be diagnosed blindly. The main reason for patients to seek medical treatment is the fear of breast cancer. The key is to conduct appropriate imaging examinations and pathological histological examinations of suspicious lesions to rule out subclinical cancer.